Literature DB >> 17158232

Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells.

Wassim El Nemer1, Marie-Paule Wautier, Cécile Rahuel, Pierre Gane, Patricia Hermand, Frédéric Galactéros, Jean-Luc Wautier, Jean-Pierre Cartron, Yves Colin, Caroline Le Van Kim.   

Abstract

The Lutheran (Lu) blood group and basal cell adhesion molecule (BCAM) antigens are both carried by 2 glycoprotein isoforms of the immunoglobulin superfamily representing receptors for the laminin alpha(5) chain. In addition to red blood cells, Lu/BCAM proteins are highly expressed in endothelial cells. Abnormal adhesion of red blood cells to the endothelium could potentially contribute to the vaso-occlusive episodes in sickle cell disease. Considering the presence of integrin consensus-binding sites in Lu/BCAM proteins, we investigated their potential interaction with integrin alpha(4)beta(1), the unique integrin expressed on immature circulating sickle red cells. Using cell adhesion assays under static and flow conditions, we demonstrated that integrin alpha(4)beta(1) expressed on transfected cells bound to chimeric Lu-Fc protein. We showed that epinephrine-stimulated sickle cells, but not control red cells, adhered to Lu-Fc via integrin alpha(4)beta(1) under flow conditions. Antibody-mediated activation of integrin alpha(4)beta(1) induced adhesion of sickle red cells to primary human umbilical vein endothelial cells; this adhesion was inhibited by soluble Lu-Fc and vascular cell adhesion molecule-1 (VCAM-1)-Fc proteins. This novel interaction between integrin alpha(4)beta(1) in sickle red cells and endothelial Lu/BCAM proteins could participate in sickle cell adhesion to endothelium and potentially play a role in vaso-occlusive episodes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158232     DOI: 10.1182/blood-2006-07-035139

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease.

Authors:  Vicky Chaar; Julien Picot; Olivier Renaud; Pablo Bartolucci; Ruben Nzouakou; Dora Bachir; Frédéric Galactéros; Yves Colin; Caroline Le Van Kim; Wassim El Nemer
Journal:  Haematologica       Date:  2010-06-18       Impact factor: 9.941

2.  Adhesive activity of Lu glycoproteins is regulated by interaction with spectrin.

Authors:  Xiuli An; Emilie Gauthier; Xihui Zhang; Xinhua Guo; David J Anstee; Narla Mohandas; Joel Anne Chasis
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

3.  Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.

Authors:  Cristiane O Renó; Amanda Rodrigues Barbosa; Sara Santos de Carvalho; Melina B Pinheiro; Danyelle Romana Rios; Vanessa F Cortes; Leandro A Barbosa; Hérica L Santos
Journal:  Ann Hematol       Date:  2020-03-12       Impact factor: 3.673

4.  The Gardos effect drives erythrocyte senescence and leads to Lu/BCAM and CD44 adhesion molecule activation.

Authors:  Thomas R L Klei; Jill J Dalimot; Boukje M Beuger; Martijn Veldthuis; Fatima Ait Ichou; Paul J J H Verkuijlen; Iris M Seignette; Peter C Ligthart; Taco W Kuijpers; Rob van Zwieten; Robin van Bruggen
Journal:  Blood Adv       Date:  2020-12-22

5.  Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation.

Authors:  Vicky Chaar; Sandrine Laurance; Claudine Lapoumeroulie; Sylvie Cochet; Maria De Grandis; Yves Colin; Jacques Elion; Caroline Le Van Kim; Wassim El Nemer
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

6.  Activation state of alpha4beta1 integrin on sickle red blood cells is linked to the duffy antigen receptor for chemokines (DARC) expression.

Authors:  Marie-Claude Durpès; Marie-Dominique Hardy-Dessources; Wassim El Nemer; Julien Picot; Nathalie Lemonne; Jacques Elion; Monique Decastel
Journal:  J Biol Chem       Date:  2010-11-18       Impact factor: 5.157

Review 7.  Emerging point-of-care technologies for sickle cell disease screening and monitoring.

Authors:  Yunus Alapan; Arwa Fraiwan; Erdem Kucukal; M Noman Hasan; Ryan Ung; Myeongseop Kim; Isaac Odame; Jane A Little; Umut A Gurkan
Journal:  Expert Rev Med Devices       Date:  2016-11-22       Impact factor: 3.166

8.  Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging.

Authors:  T R L Klei; D Z de Back; P J Asif; P J J H Verkuijlen; M Veldthuis; P C Ligthart; J Berghuis; E Clifford; B M Beuger; T K van den Berg; R van Zwieten; W El Nemer; R van Bruggen
Journal:  Blood Adv       Date:  2018-01-03

Review 9.  Sickle Cell Disease: Advances in Treatment.

Authors:  Renée V Gardner
Journal:  Ochsner J       Date:  2018

10.  Erythroid Adhesion Molecules in Sickle Cell Anaemia Infants: Insights Into Early Pathophysiology.

Authors:  Valentine Brousse; Yves Colin; Catia Pereira; Cecile Arnaud; Marie Helene Odièvre; Anne Boutemy; Corinne Guitton; Mariane de Montalembert; Claudine Lapouméroulie; Julien Picot; Caroline Le Van Kim; Wassim El Nemer
Journal:  EBioMedicine       Date:  2014-12-18       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.